The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia. (2016)
Attributed to:
Molecular determinants of Radiosensitivity
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/ncomms12308
PubMed Identifier: 27453292
Publication URI: http://europepmc.org/abstract/MED/27453292
Type: Journal Article/Review
Volume: 7
Parent Publication: Nature communications
ISSN: 2041-1723